These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 23563405)
1. Sequestration to slash research grants and delay biosimilars. Fox JL Nat Biotechnol; 2013 Apr; 31(4):271. PubMed ID: 23563405 [No Abstract] [Full Text] [Related]
2. Japan to slash huge grant scheme. Cyranoski D Nature; 2009 Oct; 461(7266):854-5. PubMed ID: 19829338 [No Abstract] [Full Text] [Related]
3. Republican spending plan casts shadow on science. Maxmen A Nature; 2012 Aug; 488(7412):441. PubMed ID: 22914144 [No Abstract] [Full Text] [Related]
4. Obama shoots for science increase. Semeniuk I; Wadman M; Young S; Hand E; Reich ES; Monastersky R Nature; 2012 Feb; 482(7385):283-5. PubMed ID: 22337024 [No Abstract] [Full Text] [Related]
5. Science agencies prepare for cuts. Wadman M Nature; 2013 Feb; 494(7436):158-9. PubMed ID: 23407517 [No Abstract] [Full Text] [Related]
6. Nanotechnology applications and implications research supported by the US Environmental Protection Agency STAR grants program. Savage N; Thomas TA; Duncan JS J Environ Monit; 2007 Oct; 9(10):1046-54. PubMed ID: 17909637 [TBL] [Abstract][Full Text] [Related]
8. Research management: What would you cut? Garman D; Cohen A; Jones B; Goldston D Nature; 2013 Jul; 499(7457):147-8. PubMed ID: 23846645 [No Abstract] [Full Text] [Related]
19. Biosimilars battle rages on, Amgen fights both sides. Senior M Nat Biotechnol; 2013 Apr; 31(4):269-70. PubMed ID: 23563402 [No Abstract] [Full Text] [Related]
20. Biosimilars and the European experience: implications for the United States. Megerlin F; Lopert R; Taymor K; Trouvin JH Health Aff (Millwood); 2013 Oct; 32(10):1803-10. PubMed ID: 24101072 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]